Trial Profile
A retrospective study analysing the variability of tacrolimus levels preceding an episode of late first episode rejection in kidney transplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Alemtuzumab
- Indications Graft-versus-host disease; Transplant rejection
- Focus Therapeutic Use
- 17 Oct 2016 New trial record